Chitosan sponges for local synergistic infection therapy: a pilot study.
about
Chitosan coating to enhance the therapeutic efficacy of calcium sulfate-based antibiotic therapy in the treatment of chronic osteomyelitisNovel Antibiotic-loaded Point-of-care Implant Coating Inhibits Biofilm.Chitosan-tripolyphosphate nanoparticles as Arrabidaea chica standardized extract carrier: synthesis, characterization, biocompatibility, and antiulcerogenic activity.Biomaterials approaches to treating implant-associated osteomyelitis.Evaluation of a chitosan-polyethylene glycol paste as a local antibiotic delivery device.Electrosprayed nanoparticles and electrospun nanofibers based on natural materials: applications in tissue regeneration, drug delivery and pharmaceuticals.Controlled local drug delivery strategies from chitosan hydrogels for wound healing.Effects of sodium acetate buffer on chitosan sponge properties and in vivo degradation in a rat intramuscular model.Hemostyptic property of chitosan: Opportunities and pitfalls.Principles of electrospraying: A new approach in protection of bioactive compounds in foods.Antibiotic-loaded phosphatidylcholine inhibits staphylococcal bone infection.Polymicrobial Biofilm Inhibition Effects of Acetate-Buffered Chitosan Sponge Delivery Device.Characterization of local delivery with amphotericin B and vancomycin from modified chitosan sponges and functional biofilm prevention evaluation.Drug self-assembly for synthesis of highly-loaded antimicrobial drug-silica particles.Local control of polymicrobial infections via a dual antibiotic delivery system.Preliminary evaluation of local drug delivery of amphotericin B and in vivo degradation of chitosan and polyethylene glycol blended sponges.
P2860
Q34686765-9A70E76A-B0B1-4A13-94CD-BD9261041250Q35689343-DDE2E79F-8814-4246-A996-D4B4FD13404BQ35743475-9C761E37-A23C-40A8-9C54-96CB706E33F8Q36555710-AF17BAC7-A0C4-48E2-8A33-05B1C98ACB03Q37648353-E845602A-81AD-462F-87F7-516D88245DC4Q38269433-47ADF9B2-A719-455A-8B42-1AAD47CF9296Q38978836-B43974DB-DBB1-4EA4-A0CA-B6B1AFC07AEDQ38988502-DB6EBA74-70EC-47D4-AA55-E51D87D81DA0Q39334894-8FFAF517-FBA5-4455-8FC5-8822532696AEQ39369465-F34729DA-5D1F-4286-89ED-681826B4217BQ40542416-F3089DE2-E489-4353-866D-B3EA34433F18Q40836726-50A74EB5-0B1C-4D35-BFD1-9A2BA03B8650Q41656458-6AAA37F2-44D6-4243-91A9-29E68786BCF9Q48223372-528FD90B-E18E-4193-B8BB-AE240793938CQ52354176-901F9377-9551-441C-B43D-27AF97D951EAQ53331064-6C568FA3-C5E7-4DE4-8914-230489A767A7
P2860
Chitosan sponges for local synergistic infection therapy: a pilot study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 April 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chitosan sponges for local synergistic infection therapy: a pilot study.
@en
Chitosan sponges for local synergistic infection therapy: a pilot study.
@nl
type
label
Chitosan sponges for local synergistic infection therapy: a pilot study.
@en
Chitosan sponges for local synergistic infection therapy: a pilot study.
@nl
prefLabel
Chitosan sponges for local synergistic infection therapy: a pilot study.
@en
Chitosan sponges for local synergistic infection therapy: a pilot study.
@nl
P2093
P2860
P1476
Chitosan sponges for local synergistic infection therapy: a pilot study.
@en
P2093
Abteen R Moshref
Harry S Courtney
J Keaton Smith
Jessica A Jennings
Warren O Haggard
P2860
P2888
P304
P356
10.1007/S11999-013-2988-5
P407
P577
2013-04-20T00:00:00Z